Department of Clinical Sciences and Community Health, Università degli Studi di Milano , Milan , Italy.
Unit of Medical Statistics and Biometry, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano , Milano , Italy.
Expert Rev Anticancer Ther. 2019 Aug;19(8):681-687. doi: 10.1080/14737140.2019.1642109. Epub 2019 Jul 15.
: Epidemiological studies indicate an association between type 2 diabetes and pancreatic cancer but the complex and multidirectional relationship between them remains unclear. : We summarized epidemiological evidence on diabetes and pancreatic cancer exploring the time-risk relationship. We described mechanisms linking long-standing diabetes to pancreatic cancer. We discussed pancreatic cancer-associated diabetes and its implication in the early detection of pancreatic cancer. : The markedly increased risk of pancreatic cancer in patients with new-onset diabetes compared with long-standing diabetes observed in several epidemiological studies indicates a complex and bidirectional connection, with long-standing diabetes being a predisposing factor for pancreatic cancer (increasing the risk of the malignancy 1.5- to 2-fold) and new-onset diabetes an early manifestation of the tumor. Identifying clinical features and biomarkers to distinguish pancreatic cancer-associated diabetes from type 2 diabetes is an important goal to improve management and survival of this cancer. Imaging (MRI) for middle-age patients with new-onset diabetes may be considered.
流行病学研究表明 2 型糖尿病与胰腺癌之间存在关联,但它们之间复杂的多向关系仍不清楚。我们总结了糖尿病与胰腺癌相关的流行病学证据,探讨了时间风险关系。我们描述了将长期糖尿病与胰腺癌联系起来的机制。我们讨论了与胰腺癌相关的糖尿病及其在胰腺癌早期检测中的意义。几项流行病学研究观察到,新发糖尿病患者的胰腺癌风险明显高于长期糖尿病患者,这表明两者之间存在复杂的双向联系,长期糖尿病是胰腺癌的一个致病因素(使恶性肿瘤的风险增加 1.5 至 2 倍),新发糖尿病是肿瘤的早期表现。确定区分与胰腺癌相关的糖尿病和 2 型糖尿病的临床特征和生物标志物是改善这种癌症管理和生存的一个重要目标。对于新发糖尿病的中年患者,可考虑进行影像学(MRI)检查。